Organisation and results of the cervical cytology screening programme in British Columbia, 1955-85.

PubWeight™: 4.60‹?› | Rank: Top 1%

🔗 View Article (PMC 2545443)

Published in Br Med J (Clin Res Ed) on April 02, 1988

Authors

G H Anderson1, D A Boyes, J L Benedet, J C Le Riche, J P Matisic, K C Suen, A J Worth, A Millner, O M Bennett

Author Affiliations

1: Division of Cytology, Cancer Control Agency of BC, Vancouver, Canada.

Articles citing this

Evaluation of the cervical cytology screening programme in an inner city health district. BMJ (1989) 5.55

Can health education increase uptake of cervical smear testing among Asian women? BMJ (1991) 5.33

Prospective randomised controlled trial of methods of call and recall for cervical cytology screening. BMJ (1989) 3.11

Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease. BMJ (1994) 2.78

Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer. Br J Cancer (1991) 2.18

Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst (2009) 2.17

Invasive cancer of the cervix in women with mild dyskaryosis followed up cytologically. BMJ (1994) 1.97

Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer (2004) 1.88

Six years' audit of laboratory workload and rates of referral for colposcopy in a cervical screening programme in three districts. BMJ (1990) 1.78

Determining use of preventive health care in Ontario: comparison of rates of 3 maneuvers in administrative and survey data. Can Fam Physician (2009) 1.56

Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer (1999) 1.55

Rate of death from cervical cancer among native Indian women in British Columbia. CMAJ (1992) 1.53

Early detection for lung cancer. New tools for casefinding. Can Fam Physician (2001) 1.51

Cervical cytology screening. How can we improve rates among First Nations women in urban British Columbia? Can Fam Physician (1996) 1.44

In vivo diagnosis of cervical intraepithelial neoplasia using 337-nm-excited laser-induced fluorescence. Proc Natl Acad Sci U S A (1994) 1.38

Abnormal cervical smear test results: old dilemmas and new directions. Br J Gen Pract (1992) 1.36

Risk targeting in cervical screening: a new look at an old problem. Br J Gen Pract (1992) 1.30

Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women. CMAJ (2001) 1.17

Chromosomal aneusomy in bronchial high-grade lesions is associated with invasive lung cancer. Am J Respir Crit Care Med (2007) 1.14

Cervical cancer screening and registration--are they working? J Epidemiol Community Health (1990) 1.13

Application of Raman spectroscopy for cervical dysplasia diagnosis. J Biophotonics (2009) 1.07

Recent trends in cervical cancer mortality in Britain and Ireland: the case for population-based cervical cancer screening. Br J Cancer (2004) 1.01

Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia: Testing a device as an adjunct to colposcopy. Int J Cancer (2010) 1.00

Pap smear screening rates: coverage on the southern queen charlotte islands. Can Fam Physician (1992) 1.00

Development of cervical cancer control interventions for Chinese immigrants. J Immigr Health (2002) 0.99

Efficiency of organised and opportunistic cytological screening for cancer in situ of the cervix. Br J Cancer (1995) 0.97

Detecting temporal and spatial effects of epithelial cancers with Raman spectroscopy. Dis Markers (2008) 0.89

Detection of pre-invasive endobronchial tumors with D-light/autofluorescence system. J Korean Med Sci (2006) 0.88

Effect of hormonal variation on Raman spectra for cervical disease detection. Am J Obstet Gynecol (2009) 0.86

Screening for squamous cell carcinoma of the cervix. Can Fam Physician (1989) 0.86

Colorectal cancer screening in asymptomatic populations. Gut (1995) 0.83

Preventive Pap-smears: balancing costs, risks and benefits. Br J Cancer (1992) 0.82

Single-visit approach of cervical cancer screening: see and treat in Indonesia. Br J Cancer (2012) 0.81

Cervical cancer screening performed by a nurse. Evaluation in family practice. Can Fam Physician (1996) 0.79

Teaching tools to engage Anishinaabek First Nations women in cervical cancer screening: Report of an educational workshop. Health Educ J (2016) 0.75

Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial. Br J Cancer (2016) 0.75

Cervical intraepithelial neoplasia. BMJ (1988) 0.75

Increase in cervical cancer mortality in Spain, 1951-1991. J Epidemiol Community Health (1999) 0.75

Evaluation of vaginal cytology in female sex-workers: A study in a tertiary hospital of eastern India. J Cytol (2014) 0.75

Ethical dilemmas of cervical cancer screening. Can Fam Physician (1992) 0.75

Perception and risk factors for cervical cancer among women in northern Ghana. Ghana Med J (2016) 0.75

Abnormal expression of integrin alpha 6 beta 4 in cervical intraepithelial neoplasia. Br J Cancer (1996) 0.75

Articles by these authors

Cervical cancer detection in British Columbia. A progress report. J Obstet Gynaecol Br Commonw (1968) 5.43

FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet (2000) 5.33

Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 4.76

A cohort study of cervical cancer screening in British Columbia. Clin Invest Med (1982) 3.80

Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 3.25

Morphometry of in vivo human white matter association pathways with diffusion-weighted magnetic resonance imaging. Ann Neurol (1997) 2.48

Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 2.47

FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet (1999) 2.36

Fine needle aspiration biopsy of the thyroid gland: a study of 304 cases. J Clin Pathol (1983) 2.13

The acceptance of the cervical cytology screening programme in the province of British Columbia. J Obstet Gynaecol Br Commonw (1967) 1.96

Qualitative and quantitative evaluation of six algorithms for correcting intensity nonuniformity effects. Neuroimage (2001) 1.90

A new histochemical technique of use in the interpretation and diagnosis of adenocarcinoma and villous lesions in the large intestine. J Clin Pathol (1977) 1.90

Elevated amygdala response to faces following early deprivation. Dev Sci (2011) 1.84

Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification. AJR Am J Roentgenol (1994) 1.69

Invasive cancer of the cervix in British Columbia: a review of the demography and screening histories of 437 cases seen from 1985-1988. Obstet Gynecol (1992) 1.66

The results of treatment of 4389 cases of preclinical cervical squamous carcinoma. J Obstet Gynaecol Br Commonw (1970) 1.66

The evaluation of cancer control measures. Br J Cancer (1973) 1.60

Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 1.54

Ten-year outcome of patients with advanced epithelial ovarian carcinoma treated with cisplatin-based multimodality therapy. J Clin Oncol (1992) 1.51

FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet (1999) 1.49

Carcinoma of the corpus uteri. J Epidemiol Biostat (2001) 1.42

Anatomy of a flexer-DNA complex inside a higher-order transposition intermediate. Cell (1996) 1.41

The T cell response to major grass allergens is regulated and includes IL-10 production in atopic but not in non-atopic subjects. Int Arch Allergy Immunol (2010) 1.40

Editorial: Cervical cytology screening. Can Med Assoc J (1974) 1.38

Role of imprint cytology in intraoperative diagnosis: value and limitations. J Clin Pathol (1978) 1.37

Carcinoma of the ovary. Int J Gynaecol Obstet (2003) 1.36

Cervical intraepithelial neoplasia in British Columbia: a comprehensive program for detection, diagnosis, and treatment. Gynecol Oncol (1981) 1.31

Carcinoma of the corpus uteri. Int J Gynaecol Obstet (2003) 1.30

CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma. J Immunol (2000) 1.30

Ovarian carcinoma: a multivariate analysis of prognostic factors. Obstet Gynecol (1985) 1.28

Second primary cancers of the breast: incidence and risk factors. Br J Cancer (1984) 1.25

Colposcopic accuracy in the diagnosis of microinvasive and occult invasive carcinoma of the cervix. Obstet Gynecol (1985) 1.25

The value of a Pap smear program and suggestions for its implementation. Cancer (1981) 1.24

Gestational trophoblastic neoplasia, FIGO 2000 staging and classification. Int J Gynaecol Obstet (2003) 1.23

A comprehensive internal quality control system for a large cytology laboratory. Acta Cytol (1988) 1.15

The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1997) 1.13

Genetic evaluation of the total hip score of four populous breeds of dog, as recorded by the New Zealand Veterinary Association Hip Dysplasia Scheme (1991-2011). N Z Vet J (2015) 1.11

A case control study into the possible effects of birth control pills on pre-clinical carcinoma of the cervix. J Obstet Gynaecol Br Commonw (1972) 1.11

Fine-needle aspiration cytology of neoplastic cysts of the pancreas. Diagn Cytopathol (1987) 1.11

The Cytology Program in British Columbia: I. An Evaluation of the Effectiveness of Cytology in the Diagnosis of Cancer and its Application to the Detection of Carcinoma of the Cervix. Can Med Assoc J (1962) 1.11

The British Columbia screening program. Obstet Gynecol Surv (1969) 1.09

Carcinoma of the ovary. J Epidemiol Biostat (2001) 1.09

Evolving a strategic approach to cervical cancer control in Africa. Gynecol Oncol (2005) 1.09

Precise segmentation of the lateral ventricles and caudate nucleus in MR brain images using anatomically driven histograms. IEEE Trans Med Imaging (1998) 1.02

Carcinoma of the vagina. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 1.02

Metastatic extraskeletal myxoid chondrosarcoma. Successful therapy with interferon alfa-2b. Chest (1995) 1.02

Post screen-detected breast cancer within the Screening Mammography Program of British Columbia. Breast Cancer Res Treat (1997) 1.02

Apocrine carcinoma of the lip: a case report including immunohistochemical and ultrastructural study, discussion of differential diagnosis, and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1996) 1.01

The use of imprint technic for rapid diagnosis in postmortem examinations. A diagnostically rewarding procedure. Am J Clin Pathol (1976) 1.00

The spectrum of eosinophilic infiltration of the gastrointestinal tract and its relationship to other disorders of angiitis and granulomatosis. Hum Pathol (1979) 1.00

Ten years of breast screening in the Screening Mammography Program of British Columbia, 1988-97. J Med Screen (2000) 0.99

Recent results from the British Columbia screening program for cervical cancer. Am J Obstet Gynecol (1977) 0.99

Experience with cervical screening in British Columbia. Gynecol Oncol (1981) 0.99

The performance of fluorescence and reflectance spectroscopy for the in vivo diagnosis of cervical neoplasia; point probe versus multispectral approaches. Gynecol Oncol (2007) 0.98

The clinical effectiveness of optical spectroscopy for the in vivo diagnosis of cervical intraepithelial neoplasia: where are we? Gynecol Oncol (2007) 0.97

A comprehensive program for cervical cancer detection and management. Am J Obstet Gynecol (1992) 0.95

CXC chemokine receptor 3 expression on CD34(+) hematopoietic progenitors from human cord blood induced by granulocyte-macrophage colony-stimulating factor: chemotaxis and adhesion induced by its ligands, interferon gamma-inducible protein 10 and monokine induced by interferon gamma. Blood (2000) 0.94

Accuracy of colposcopy in the diagnostic setting compared with the screening setting. Obstet Gynecol (2008) 0.94

Congenital generalized fibromatosis: an autosomal recessive condition? Clin Genet (1976) 0.94

Adenocarcinoma of the fallopian tube. Experience with 41 patients. Obstet Gynecol (1977) 0.94

The comet assay in clinical practice. Acta Oncol (1999) 0.93

Carcinoma of the fallopian tube. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 0.90

Cervical intraepithelial neoplasia in female prisoners in British Columbia. CMAJ (1988) 0.89

Forty years of repeated screening: the significance of carcinoma in situ. Br J Cancer (1996) 0.89

Clinical and pathological features and survival of endometrial cancer patients in relation to prior use of estrogens. Gynecol Oncol (1980) 0.89

The use of exfoliative vaginal cytology in pregnancy. Am J Obstet Gynecol (1966) 0.89

Diet and histologic types of benign breast disease defined by subsequent risk of breast cancer. Am J Epidemiol (1990) 0.89

Needle aspiration biopsy in cystic papillary carcinoma of the thyroid. AJR Am J Roentgenol (1985) 0.89

The Walton report and its subsequent impact on cervical cancer screening programs in Canada. Obstet Gynecol (1984) 0.89

Two unusual benign lesions of the neck masquerading as malignancy on fine-needle aspiration cytology. Diagn Cytopathol (1995) 0.89

Cytologic features of papillary serous adenocarcinoma of the uterine cervix. Cancer (1997) 0.88

Natural history of cervical intraepithelial neoplasia: a meta-analysis. Acta Cytol (2005) 0.88

Human papillomavirus and cervical intraepithelial neoplasia in women who subsequently had invasive cancer. CMAJ (1990) 0.87

Multiple gingival metastases from angiosarcoma of the breast. Oral Surg Oral Med Oral Pathol (1987) 0.86

Primary hepatic lymphoma: two case reports and a review of the literature. Med Pediatr Oncol (1982) 0.86

Treatment of 126 cases of advanced ovarian carcinoma with cyclophosphamide. Can Med Assoc J (1968) 0.86

Radical hysterectomy in the treatment of cervical cancer. Am J Obstet Gynecol (1980) 0.86

Plasma cell leukemia following treatment with radiotherapy and melphalan. Can Med Assoc J (1977) 0.86

Granulosa cell tumors. A clinical review of 61 cases. Obstet Gynecol (1978) 0.85

Advantages of routine step serial sectioning of cervical cone biopsies. Am J Clin Pathol (1968) 0.85

An analysis of 84244 patients from the British Columbia cytology-colposcopy program. Gynecol Oncol (2004) 0.85

Diagnosis of primary hepatic neoplasms by fine-needle aspiration cytology. Diagn Cytopathol (1986) 0.84

The results of cryosurgical treatment of cervical intraepithelial neoplasia at one, five, and ten years. Am J Obstet Gynecol (1987) 0.84

Some cytologic features of hepatocellular carcinoma as seen in fine needle aspirates. Acta Cytol (1985) 0.84

The endocrinology and treatment of prostate tumor progression. Prog Clin Biol Res (1987) 0.83